SAMUS THERAPEUTICS INC has a total of 18 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are LEIUTIS PHARMACEUTICALS PVT LTD, HUNAN QIANJIN XIELI PHARMACEUTICAL CO LTD and FARMATEN AVEE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Singapore | 2 | |
#7 | Taiwan | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Israel | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Amedio John | 10 |
#2 | Wallner Barbara P | 6 |
#3 | Wallner Barbara | 1 |
Publication | Filing date | Title |
---|---|---|
EP3641751A2 | Epichaperome inhibitor therapy for traumatic brain injury and sequelae thereof | |
KR20190138871A | HSP90 Inhibitor Oral Formulations and Related Methods |